Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | -4.14% |
|
-1.42% | +32.07% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 8M | Capitalization | 83.74M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -37M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.5 x |
P/E ratio 2024 * |
-2
x | P/E ratio 2025 * |
-2.42
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.73% |
Latest transcript on SELLAS Life Sciences Group, Inc.
1 day | -3.10% | ||
1 week | +0.70% | ||
Current month | +1.42% | ||
1 month | +5.54% | ||
3 months | +5.54% | ||
6 months | +38.83% | ||
Current year | +34.91% |
![Extreme 1.36](/images/extremecours_fleche.png)
![Extreme 1.3](/images/extremecours_fleche.png)
![Extreme 0.4986](/images/extremecours_fleche.png)
![Extreme 0.4986](/images/extremecours_fleche.png)
![Extreme 0.4986](/images/extremecours_fleche.png)
![Extreme 0.4986](/images/extremecours_fleche.png)
![Extreme 0.4986](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Angelos Stergiou
FOU | Founder | 48 | 06-04-02 |
John Burns
DFI | Director of Finance/CFO | 39 | 13-04-30 |
Andrew Elnatan
LAW | General Counsel | - | 23-01-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 17-12-28 | |
David Scheinberg
BRD | Director/Board Member | 68 | 17-11-30 |
John Varian
BRD | Director/Board Member | 64 | 17-12-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 1.39 | -4.14% | 725 319 |
24-06-07 | 1.45 | -1.36% | 552,168 |
24-06-06 | 1.47 | -0.68% | 622,710 |
24-06-05 | 1.48 | +4.96% | 685,451 |
24-06-04 | 1.41 | -0.70% | 360,519 |
Delayed Quote Nasdaq, June 10, 2024 at 10:02 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.91% | 83.74M | |
+17.92% | 125B | |
+13.20% | 108B | |
-6.93% | 24.21B | |
+0.93% | 22.78B | |
-11.07% | 17.96B | |
-41.74% | 16.43B | |
-13.61% | 16.37B | |
+1.09% | 13.58B | |
+27.81% | 11.66B |
- Stock Market
- Equities
- SLS Stock